TELMISARTAN 40mg / AMLODIPINE 5mg, tab.

STD DORATEAM45T

Valid Article

12.3 - Antihypertensive medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C09DB04
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

TELMISARTAN / AMLODIPINE

Therapeutic Action

Fixed-dose combination (FDC) of two antihypertensives:

  • telmisartan: angiiotensin II receptor blocker
  • amlodipine: dihydropyridine calcium channel blocker

Indications

First-line treatment of essential hypertension in adults

Additional treatment in patients whose blood pressure is not adequately controlled by amlodipine alone.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Start with 1 tablet daily, increase to a maximum of 2 tablets daily as needed to achieve a target BP <140/90.

Contact your NCD advisor for adapted protocol.

Precautions for Use

Closely monitor the blood pressure.

Contraindicated in pregnancy and breastfeeding.

Administer with caution to patients with cholestasis, biliary obstructive disorders or hepatic impairment, renal artery stenosis, aortic or mitral stenosis, or obstructive hypertrophic cardiomyopathy (HOCM).

Storage

Below 25°C - Protect from sunlight - Protect from humidity